Logo

American Heart Association

  10
  0


Final ID: Sa1015

Mapping the Molecular Progression of Human Coronary Atherosclerosis Confirms Key Role of Smooth Muscle Cell Phenotype and Highlights Novel Regulators of Phenotypic Fate

Abstract Body (Do not enter title and authors here): Background: clarity in the molecular mechanisms contributing to pre-clinical stages of coronary atherosclerosis is needed to develop novel early diagnostic tools and more effective preventive interventions.
Methods: We completed untargeted proteomic and RNA expression analysis on proximal coronary arterial (CA) tissues from young adults who died of trauma with no antemortem suspicion of coronary disease (n=322, mean age (range): 34.1 yrs. (15-59); sex: M-239, F-83; race: W-218, B-88, other-16), including n=180 (56%) with morphologic evidence of pre-clinical atherosclerosis. Proteomic data (n=1900 proteins) were analyzed using manifold learning and unsupervised latent feature (LF) detection methods to define the pseudo-temporal progression of disease from normal to advanced atherosclerosis and to identify molecular drivers of disease initiation and progression. Correlation and network mapping of the mRNA data (n=16,707 transcripts, including n=1707 annotated transcription factors [TFs]) from the same arterial samples was used to define the transcriptional regulatory networks (TRNs) associated with the observed proteomic LF dynamics.
Results: Four of seven identified LFs had a significant (FDR Conclusions: The pseudotemporal pattern of the SMC LF was consistent with SMC phenotype changes as early initiating events in atherosclerosis of the CA. Therapies to promote or inhibit activity of these identified TFs may prevent against early lesion formation and atherosclerosis progression by supporting SMC phenotype stability.
  • Parker, Sarah  ( Cedars-Sinai Medical Center , W Hollywood , California , United States )
  • Caudell, David  ( Wake Forest School of Medicine , Winston Salem , North Carolina , United States )
  • Vanderheide, Richard  ( Marshfield Clinic Health System , Marshfield , Wisconsin , United States )
  • Hixson, James  ( UTHealth School of Public Health , Houston , Texas , United States )
  • Van Eyk, Jennifer  ( CEDAR SINAI MEDICAL CENTER , West Hollywood , California , United States )
  • Wang, Yue  ( Virginia Tech , Blacksburg , Virginia , United States )
  • Herrington, David  ( WAKE FOREST UNIV SCHOOL MEDICI , Winston Salem , North Carolina , United States )
  • Mao, Chunhong  ( University of Virginia , Charlottesville , Virginia , United States )
  • Wang, Yizhi  ( Virginia Tech , Blacksburg , Virginia , United States )
  • Seals, Austin  ( Atrium Health Wake Forest Baptist , Winston-Salem , North Carolina , United States )
  • Kim, Do-kyun  ( UTHealth, School of Public Health , Houston , Texas , United States )
  • Lu, Yingzhou  ( Virginia Tech , Ballston , Virginia , United States )
  • Bhardwaj, Saurabh  ( Virginia Tech , Ballston , Virginia , United States )
  • Du, Dongping  ( Virginia Tech , Ballston , Virginia , United States )
  • Karere, Genesio  ( Wake Forest School of Medicine , Winston Salem , North Carolina , United States )
  • Author Disclosures:
    Sarah Parker: DO NOT have relevant financial relationships | David Caudell: No Answer | Richard Vanderheide: No Answer | James Hixson: DO NOT have relevant financial relationships | Jennifer Van Eyk: DO NOT have relevant financial relationships | Yue Wang: DO NOT have relevant financial relationships | David Herrington: DO have relevant financial relationships ; Researcher:esperion:Past (completed) ; Researcher:amgen:Active (exists now) ; Researcher:astra zenica:Active (exists now) | Chunhong Mao: DO NOT have relevant financial relationships | Yizhi Wang: DO NOT have relevant financial relationships | Austin Seals: No Answer | Do-Kyun Kim: DO NOT have relevant financial relationships | Yingzhou Lu: DO NOT have relevant financial relationships | saurabh bhardwaj: No Answer | Dongping Du: DO NOT have relevant financial relationships | Genesio Karere: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Phenotypic Profiling of Cardiovascular Dysfunction

Saturday, 11/16/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts on this topic:
ABO Blood Type, Plasma Proteomic Profile, and Risk of Chronic Disease

Jia Chengyong, Zhang Yanbo, Luo Kai, Kaplan Robert, Rohan Thomas, Qi Qibin

A Randomized Placebo-Controlled Trial of Pitavastatin Calcium to Treat Combined Dyslipidemia of Obesity in Adolescents – The Pediatric Heart Network Dyslipidemia of Obesity Intervention in Teens (DO IT!) Trial

De Ferranti Sarah, Cartoski Mark, Brothers Julie, San Giovanni Christine, Zachariah Justin, Pena Sandra, Mahle William, Peterson Amy, Magge Sheela, Raghuveer Geetha, Sharma Binu, Arslanian, Md Silva, Kazlova Valiantsina, Sponseller Craig, Freemon Dandrea, Stylianou Mario, Mccrindle Brian, Mietus-snyder Michele, Urbina Elaine, Ware Adam, Teng Jessica, Trachtenberg Felicia, Russell Mark, Shah Amy

More abstracts from these authors:
Intensive Hypertension Management and Incident Heart Failure Risk for Blacks versus Non-Blacks: Insights From SPRINT

Hammonds Racquel, Kazibwe Richard, Gabani Mohanad, Mirzai Saeid, Herrington David, Shapiro Michael

ECG-AI to Assist with the Classification of Low Ejection Fraction and Heart Failure with Preserved Ejection Fraction

Karabayir Ibrahim, Kitzman Dalane, Herrington David, Akbilgic Oguz, Davis Robert, Tootooni M. Samie, Chinthala Lokesh, Soliman Elsayed, Jefferies John, Baykaner Tina, Shah Sanjiv, Bertoni Alain

You have to be authorized to contact abstract author. Please, Login
Not Available